ERBB2 and neoplasm: The biodistribution of (HE)3-G3 was assessed in HER2 tumour-bearing mice, and this construct was chosen on the basis of its lower normal tissue uptake (Figs. 4 and 5), which could facilitate imaging of HER2-positive tumours by achieving greater contrast between tumours and normal tissues.